hackettg

The Department of Health and Social Care (DHSC) determined that from February 2023 onwards, Transitional Payments would be set to zero. This is reflected in the February Schedule of Payments received by contractors this month. In discussions with DHSC, PSNC had rejected the change to the Transitional Payments on the grounds that any further reductions [...]

The post Contractor reminder: Transitional Payments set to zero from February appeared first on PSNC Website.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 May 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]

The post Drug Tariff Watch – May 2023 appeared first on PSNC Website.

Class 4 Medicines Defect Information: Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension (Sandoz Limited) Drug alert number: EL (23)A/14 Date issued: 20 April 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name: Co-amoxiclav 125/31.25mg/5ml powder for oral suspension, PL 04416/0514 (Sandoz Limited) SNOMED [...]

The post MHRA Class 4 Medicines Defect Information: Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension (Sandoz Limited) appeared first on PSNC Website.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 April 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]

The post Drug Tariff Watch – April 2023 appeared first on PSNC Website.

Following representation from PSNC, the NHS Business Services Authority (NHSBSA) has added the ‘Caution – AMP level prescribing advised’ marker to oral Tacrolimus products on the Dictionary of medicines and devices (dm+d). This is in line with the MHRA guidance that oral Tacrolimus products should be prescribed and dispensed by brand name only, to minimise [...]

The post Brand name prescribing status for Tacrolimus products updated on dm+d appeared first on PSNC Website.